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ABSTRACT 
In this study I investigated the effects of 192-lgG saporin injections into the medial 
septal area. (MSA) and nucleus basalis magnocel/ularis (NBM) on radial arm maze 
performance in the male rat. The results of the present study reveal that combined 
injections of 192-lgG saporin into the basal forebrain failed to disrupt RAM performance 
when compared to vehicle-injected controls. In addition, intraperitoneal injections using a 
muscarinic receptor blocker, scopolamine, failed to reveal a compensatory response of the 
cholinergic basal forebrain that may have explained the lack of behavioral effects of 192­
IgG saporin. Consequently, the results of this study suggest that a selective reduction in 
cholinergic transmission in the basal forebrain is, by itself, insufficient to account for the 
functional impairments observed in spatial learning in the rat. These data do not support 
the use of 192-lgG saporin as a viable approach to the elucidation of the 
neuropathological mechanisms that are associated with the cognitive deficits seen in 
Alzheimer's Disease. 
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Alzheimer's disease (AD) is a neurodegenerative disorder that currently afflicts 
approximately 4 million people in the United States, with roughly 100,000 new cases 
diagnosed ~ach year 19. AD is characterized by progressive deterioration of memory, 
cognition, and personality 19. Pathologically, the hallmarks of AD are the appearance of 
neuritic plaques and neurofibrillary tangles in various regions of the brain, and extensive 
neuronal damage and loss 40. While progress has been made toward an understanding 
of the etiology of AD 12,18,39, currently there is no animal model that mimics the profound 
pathological and behavioral deficits that characterize the disease. For this reason, our 
laboratory has focused on the behavioral changes that occur in animals who receive 
bilateral injections of different fragments of B-amyloid (the major constituent of the neuritic 
plaque, a pathological hallmark of AD) into the hippocampus. We have previously 
reported that bilateral injections of B-amyloid in the hippocampus along with a 
subthreshold dose of the neurotoxin ibotenic acid induce a dramatic impairment in the 
acquisition of spatial learning in the rat 9. Another approach that our laboratory has taken 
recently is to mimic the loss of the cholinergic projections to the hippocampus and cortex 
using a variety of lesion techniques and to determine how the loss of these fibers affects 
learning and memory in the rat. The latter approach is the focus of my project. 
In AD patients, there is a decrease in the amount of cholinergic input from the 
basal forebrain to the hippocampus and cortex 15. A correlation between this gradual 
depletion and the learning and memory deficits characteristic of AD patients has been 
reported in several studies 13,31,33. The resulting theory, called the cholinergic denervation 
hypothesis of AD, infers a causal relationship between the loss of acetylcholine (ACh) in 
5 
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the cortex and hippocampus, and the cognitive deficits. In support of the cholinergic 
hypothesis, these affected areas are intimately involved in learning and memory. 
The most prominent projection in the mammalian basal forebrain is a projection 
from the medial septal area (including the diagonal band of Broca) to the hippocampus, 
in addition to a cortical projection that originates from the nucleus basalis magnocellularis 
25. Collectively, these t\NO areas account for approximately 80-90% of the cholinergic input 
to the hippocampus and cortex respectively. Accumulating evidence from a large number 
of studies done in the rat reveal that disruption of the functional integrity of the cholinergic 
basal forebrain (CBF) projection to the hippocampus and cortex using cholinergic 
antagonists 22,30, or specific lesions of the medial septal area (MSA) and nucleus basalis 
magnocellularis (NBM), induce marked impairments of a variety of behavioral tasks, 
particularly those that involve spatial learning 2,6-8,14,26. More specifically, consid~rable 
evidence suggests that, on the average, lesions of the MSA or NBM induce substantial 
spatial learning impairments on both the Morris water maze (MWM) and the radial arm 
maze (RAM). These impairments are associated with marked reductions in choline 
acetyltransferase (ChAT), which is an index of cholinergic activity. 
In the past, many of the lesions of the MSA or NBM have been done using 
relatively non-selective techniques. For example, in addition to the inherent problem of 
damage to "fibers of passage," electrolytic lesions of the NBM often induce damage to 
surrounding area (e.g. globus pallidus), and not only reduce cholinergic transmitters, but 
other neurotransmitters as well. This is particularly problematic with MSA and NBM 
lesions as cholinergic neurons in these areas are scattered among a plethora of non­
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cholinergic neurons. While the use of excitotoxins circumvent many of the problems 
inherent with electrolytic lesions, most induce considerable damage to adjacent structures 
via significant diffusion from the injections site. Not surprisingly, when studies have been 
done using the aforementioned techniques to assess the effects of lesions of the N8M and 
MSA on spatial learning in the rat, conflicting results have been reported. For instance, 
although marked impairments of spatial learning have been observed on performance of 
either the radial arm maze or morris water maze 23,26,27, others have found either no 
appreciable effects 24.32 or differential effects when assessing spatial learning with either 
the radial arm maze or the morris water maze 6 depending on the excitotoxin used. These 
studies have seriously questioned previous interpretations of spatial learning impairments 
induced by ibotenic acid in terms of cholinergic loss. Several investigators have 
suggested that the spatial impairments observed following excitotoxic lesions of the basal 
forebrain may be resulting from loss of non-cholinergic neurons 11. 
Not surprisingly, there has been pressure to develop neurotoxins specific to the 
cholinergic system. One such neurotoxin, called ethylcholine aziridinium mustard ion 
(AF64A) was introduced by Dr. Israel Hanin about ten years ago. AF64A is selectively 
taken up by cells with choline uptake sites. AF64A produces reliable impairments on a 
variety of spatial tasks, and has been proposed as a model of the cholinergic denervation 
of AD 29,34. More recently, saporin, a specific neurotoxin, has been developed. Saporin 
is a ribosome-inactivating protein derived from the fern Saporin offininalis, and when 
coupled to a monoclonal antibody against the p7510w affinity nerve growth factor receptor 
(NGFr) is a selective cholinergic toxin (192-lgG-saporin) 45. Within the basal forebrain, the 
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p75 NGFr is located exclusively on cholinergic cell bodies in the MSA and NBM that 
project to the hippocampus and cortex, but not to the amygdala 16. Intraventricular 
injections of 192 IgG saporin cause, by seven days, a permanent 80-90% depletion of 
acetylcholine levels in the cortex and hippocampus, while having minimal effects on other 
transmitter systems 5. 
192-lgG-Saporin seems an idea tool for studying the components of the basal 
forebrain cholinergic system as they relate to memory, since it can be injected both 
intraventricularly and directly into the areas where a lesion is desired. However, although 
the neurotoxic effects of 1921gG-saporin are specific, the effects of saporin injections into 
the basal forebrain on learning and memory have produced inconsistent results. In the 
first published study on the effects of 192-lgG saporin on spatialleaming in the rat, Nilsson 
et al 30 reported that intraventricular injections of 192-lgG saporin which produced ~ 85­
90% reduction of ChAT activity in the hippocampus, induced a long-lasting deficit on water 
maze performance in female rats when compared to controls. However, a subsequent 
study by Torres et al 41 found that, following intraventricular injections, there was a 70-90% 
depletion of AChE in the hippocampus and cortex but no deficits in water maze 
performance. A study by Baxter et al 3 showed that neither NBM lesions nor MSA lesions 
had any effect on water maze performance, although they too found a marked depletion 
of cholinergic markers. In contrast, Berger-Sweeney et al 4, after finding the same 
cholinergic depletions, found that the intraventricular and NBM lesions caused deficits in 
water maze performance, while the MSA lesion had hardly any effect. Clearly, the above 
studies indicate that despite consistent reductions of ChAT activity in the basal forebrain 
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following injections of 192-lgG saporin, a wide disparity of effects on spatial learning in the 
rat exists following injections of 192-lgG saporin. For example, thus far at least 4 studies 
have been pl:Jblished 3.4,37,38 that have reported a lack of effect on spatial learning in the rat 
despite a 70-90% reduction of basal forebrain acetylcholine. In the studies that have 
reported an impairment of spatial learning following intraventricular injections of saporin, 
all have noted that the effects observed may be due to loss of cerebellar NGFr-positive 
Purkinje cells following intraventricular injections of 192-lgG saporin. In a recent article 
published by Walsh et al 43, the authors conclude that although 192-lgG saporin is a highly 
selective cholinergic toxin, the secondary effects induced by intraventricular injections of 
192-lgG saporin "makes the i.c.v. model of 192 IgG saporin problematic for studying the 
role of the CBF in normative behavior and in disease states." The authors further suggest 
that site-specific injections of 192-lgG saporin would provide a viable approach to 1T!0dei 
Alzheimer's Disease. In order to circumvent the problem of cerebellar Purkinje cell 
damage following i.c.v injection of 192-lgG saporin, while at the same time producing a 
cholinergic lesion that essentially destroys the cholinergic input to the hippocampus and 
cortex in the rat, we have employed a "combined lesion" technique where the animals 
receive stereotaxic injections into the medial septal area, and (bilateral) injections into the 
nucleus basalis magnocellularis. These injections produce very selective lesions of the 
CBF while at the same time avoiding the inherent problems associated with intraventricular 
injections of 192-lgG saporin. 
In a previous study done in this lab using the "combined lesion" approach 10, we 
investigated the effects of 192-lgG saporin injections into the MSA, NBM, or combined 
9 
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injections into the MSA and NBM on water maze and radial arm maze performance in the 
male rat. We reported a dissociation between the effects of 192-lgG saporin injections 
into the basal forebrain on the performance of the two tasks of spatial learning in the rat. 
Bilateral injections of 192-lgG saporin into the NBM, MSA, or combined MSAlNBM failed 
to disrupt water maze performance when compared to controls. In contrast, injections of 
192-lgG saporin into the MSA, NBM, or MSAlNBM induced impairments on the radial arm 
maze task. Overall, the disruption of spatial learning observed in this study was relatively 
mild compared to deficits in spatial learning reported using less selective lesions of the 
cholinergic basal forebrain. 
The current project attempts to expand upon the previous study. In addition to the 
single MSA and bilateral NBM injections, we added a second group that received two 
additional injections of 192-lgG saporin into the MSA (bilateral), to determine whet,her a 
more complete lesion of the MSA (and thus a greater depletion of acetylcholine) will 
disrupt performance of a radial arm maze spatial memory task. 
All of the studies that have been published using saporin have assessed 
acquisition of spatial tasks. Perhaps more profound effects of selectively disrupting the 
cholinergic system would be observed in animals that have already learned the task. 
Therefore, in this study, in addition to more extensive lesions of the cholinergic basal 
forebrain, the animals were pretrained on the radial arm maze. After they established 
criteria, they were given the 192-lgG saporin injections and retested on the radial arm 
maze. The partially baited paradigm allows measurement of both reference memory 
(vvhich arms are baited throughout all trials) and recent memory (the running list of which 
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arms have and have not been visited during a trial). A modified version of the RAM task 
was used in the second experiment, in which the trial was interrupted by a five-minute 
delay after th~ rat had visited three baited arms. This allows for measurement of two kinds 
of recent memory: retroactive (the rat's memory of which three baited arms it has visited 
before the delay) and proactive (its memory of arms visited during the postdelay session). 
METHODS: 
Animals 
Thirty-four male Long-Evans rats, obtained from Harlan Sprague-Dawley, ranging 
in age between 4 and 6 months and weighing approximately 250-350 g were used in this 
study. The rats were individually housed in hanging stainless steel cages ,in a 
temperature-controlled environment (20°C) on a 10:14 lightdark cycle (lights on a 0600 
and off at 2000). During radial arm maze testing before and after surgery, all animals were 
food deprived to 85% their ad libitum weight. 
Surgery 
Once all animals had established criteria (Le., group means of < 2 recent memory 
errors and ~ 1 reference memory errors), they were brought back to their ad libitum 
weights in preparation for surgery. The animals were assigned to four groups such that 
the mean performance of all measures (reference and recent memory errors, and choice 
latency) in every group was statistically identical. Since it has been demonstrated that 
injections of 192-lgG alone do not produce neurotoxic damage, or effects on spatial 
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learning 4,45, all control injections were done using the 0.05% sodium azide solution (0.6 
1J1/per injection). At this dose, sodium azide does not affect spatial learning 10. Each rat 
was anesthetized with sodium pentobarbitol (50 mglkg) and received stereotaxic injections 
via a 1 IJL Hamilton syringe of O.84IJg/IJL of 192-lgG saporin (Lot # 31795031, Chemicon) 
dissolved in a 0.05% sodium azide solution. One half of the animals received two bilateral 
injections into the nucleus basalis magnocellularis (AP: -o.8mm; ML: +3.6mm; DV: -5.9mm) 
and one injection into the medial septal area (AP: +1.8mm; ML: Omm; DV: -6.0mm). The 
other half received these injections plus two additional injections into the medial septal 
area (AP: +1.8mm; ML: +1.0, -1.0mm; DV: -7.0mm). All coordinates are from dura. 
In order to prevent backflow and minimize tissue damage, all injections took place 
over a three minute interval, and the needle was left in place after the injection for an 
additional five minutes. The needle was also raised and lowered over an interval of four 
minutes. The coordinates for all injections were empirically determined using the Atlas of 
Paxinos and Watson as a guide 35. 
Apparatus and Behavioral Testing 
Experiment 1: Standard RAM Task 
The testing apparatus consisted of a partially baited 8-arm (5 arms baited) radial 
arm maze (RAM). Prior to surgery, all animals were trained to perform the RAM task to 
criteria, which was designated as making no more than two errors. The animals were 
exposed to a habituation period of four days, during which reinforcers (cheerios) ,were 
liberally scattered on the RAM. Three animals were placed on the center platform and 
allowed to explore for 5 minutes. Following the adaptation phase, each animal was tested 
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alone over a period of three weeks until it met criteria. The RAM consisted of 8 arms, of 
which 5 were baited with reinforcers. The baited and unbaited arms remained constant 
throughout the experiment. At the beginning of the RAM task, each animal was placed in 
the center of the maze and permitted to choose among the arms until it had successfully 
completed the task (obtained all five reinforcers), or until five minutes had elapsed. The 
following behavioral parameters were recorded: 1) recent memory errors: total number of 
reentries into any arms, 2) reference memory errors: first entry into arms that were never 
baited, and 3) choice latency, calculated by dividing total trial latency by the total number 
of choices. 
Six days after the animals had reached criteria, stereotaxic surgery was performed. 
Following a two week recovery period, all animals were given at least three trials to 
reestablish a baseline performance on the RAM. If the animal did not complete the, task 
within five minutes, it was removed from the maze and the data from that trial was not 
counted in the final analyses. Testing continued for a total of sixteen days, with a two­
week break between the twelfth and thirteenth day of testing. 
Experiment 2: Delay Condition 
Following completion of the standard testing, there was a 5 minute delay imposed 
in the middle of the trial. The rat was allowed to find three of the reinforcers, then removed 
from the maze and made to wait five minutes in the carrier. The rat was then returned to 
the maze, and only the two of the original five arms remained baited (the two it had not 
previously visited). The rat was then allowed to run until it had found the remaining 
reinforcers. The following parameters from the postdelay session of the trial were 
13 Basal Forebrain Lesions and Memory 
recorded: 1) Reference memory errors: entry into an arm that was never baited; 2) 
Retroactive memory errors: entry into an arm that had been baited and visited during the 
predelay session; 3) Proactive memory errors: reentries into any arm. Animals that did not 
finish either the predelay or postdelay task within five minutes were excluded from the 
analysis for that day. Testing continued for a total of nine days. There was an added 
distraction as well; in the break between experiment one and two there was a central 
"doorway" which included guillotine doors leading to each arm installed onto the maze. 
These were not used during the course of the remaining experiments and were kept open 
at all times. 
Scopolamine Treatment and Behavioral Testing 
Following the completion of the delay testing, all animals were randomly assigned 
to receive one of three drug treatments. They received an IP injection of either sterile 
saline, scopolamine at a low dose (0.03mglkg), or scopolamine at a high dose (0.3 mg/kg). 
Fifteen minutes after the injections, the animals were again tested on the RAM, with a five­
minute delay between the third and forth choices. Animals were tested again two days 
later, after the drug had worn off, to ensure that there were no carryover effects from the 
injections. They then received another different dose of the drug, followed by the RAM test 
immediately after and two days later. Animals in this way received two doses of the drug 
and one control injection. 
Neurochemical Analysis and Histological Verification and ChAT Analysis: 
The brains of the animals will be processed following completion of the testing. 
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RESULTS: 
Of the 34 animals that began the experiment, one died of an infection unrelated to 
the saporin lesions during Experiment 2. That animal's data was included up to the point 
that it could no longer run (in block 2). That left 33 animals for data analysis: MSA (1)/ 
NBM (saporin), n=12; MSA (3)/ NBM (saporin), n=11; MSA (1)/ NBM (vehicle), n=5; and 
MSA(3)/ NBM (vehicle), n=5. 
Experiment 1: 
Animals were tested for sixteen days. All scores were summed and averaged over 
blocks comprised of two days per block. It was clear that the two control groups did not 
differ in their performance during the first few blocks, and separate ANOVA's by injection 
site in the control groups did reveal a non significant difference (p >0.05). All subsequent 
data for the two groups were combined and the group collectively referred to as "controls." 
The mean number of reference memory errors and recent memory errors during 
the eight blocks of standard RAM testing are illustrated in Figures 1a and 1b, respectively. 
The average latency per choice is shown in Figure 1c. 
A 3 x 8 mixed ANOVA with blocks as the repeated measure and injection condition 
as the between measure revealed a significant main effect of injection site for reference 
memory errors, F(2,64) = 6.12, P < 0.003. However, the analysis revealed a non­
significant block by injection condition interaction F(14, 448)= 1.19, p> 0.05. Pas hoc 
analysis revealed that on blocks 5 and 7, the MSA 1/NBM group was significantly different 
from the MSA 3/ NBM group, and on block 6, the control group was significantly different 
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than the MSA 3/ NBM group. 
Analysis of recent memory errors revealed no main effect, F(2,64) = 0.14, P > 0.05, 
and no interCiction, F(14, 448=1.49), P > 0.05. This demonstrated that saporin injections 
into the MSA and NBM combined had no effect on recent memory as measured by the 
RAM task. 
Analysis of choice latency showed both a significant main effect of injection site, 
F(2,64) = 7.06, P < 0.002. There was also significant block by injection condition 
interaction F(14,448) = 2.28, P < 0.005. Post hoc analysis revealed that, overall, the 
animals with 3 injections to the MSA and 2 to the NBM had significantly faster choice 
latencies than the other two groups on all blocks except 5 and 8. This is illustrated in 
Figure 1c. 
Experiment 2: 
Animals 'Nere tested for a total of nine days, and the data was combined into blocks 
of 3 days per block. Mean reference memory errors, retroactive errors, and proactive 
errors, are displayed in Figure 2a, 2b, and 2c, respectively. 
A 3 x 3 mixed ANOVA with blocks as the repeated measure and injection condition 
as the between variable on reference memory errors revealed a non-significant main effect 
of injection condition, F(2,99) = 0.15, P > 0.05. There was also a non-significant block by 
injection condition interaction, F(4,198 )=0.25, P > 0.05. The results show that 192­
Saporin lesions of the MSA and NBM had no significant effect on performance of the .RAM 
task 'Nhen compared to controls, even after a delay of five minutes was imposed during the 
middle of the trial. 
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Likewise, analyses of retroactive errors and proactive errors also revealed non­
significant main effects of injection conditions, F(2,99) = 0.401, p>0.05; and F(2,99) = 0.08, 
p> 0.05, respectively. It also revealed non-significant interactions of block and injection 
condition F(4, 198) = 0.34,P>0.05; and F(4,198)= 0.34, p>0.05. 
Analysis of choice latency revealed a non-significant main effect of injection 
condition, F(2,99)=0.91, p>0.05, and a non-significant interaction, F(4, 198)=0.90, p> 0.05. 
(graph not shown). 
Overall, these data indicate that 192-lgG saporin, injected into the basal forebrain, 
had no effect on any of the measures of this task in rats when compared to vehicle-injected 
controls. 
Experiment 3: 
Figure 3a, 3b, and 3c illustrate reference memory errors, retroactive memory 
errors, and proactive errors in animals which have received either saline or scopolamine 
injections fifteen minutes prior to the trial. 
A 3 x 3 mixed ANOVA with injection condition as the first between variable and 
scopolamine dose as the within variable on reference memory errors revealed a non­
significant main effect of injection condition, F(2,30)=2.95, p> 0.05, and a non-significant 
injection condition by scopolamine dose interaction F(4,60)=0.25, p> 0.05. 
A similar analysis of retroactive memory errors also revealed a non-significant main 
effect of injection condition, F(2,30)=0.17, p > 0.05, as well as a non-significant injection 
condition by scopolamine dose interaction, F(4,60)=1.15, p > 0.05. 
An analysis of proactive errors did reveal a significant main effect of injection site, 
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F(2,30)=4.54, P < 0.02, as well as an injection site by scopolamine dose interaction, 
F(4,60)=4.54, p < 0.003. Post hoc analysis of proactive errors, however, revealed that the 
interaction was only seen using the highest dose of scopolamine. The MSA 1/ NBM group 
made significantly more errors than did the MSA 3/ NBM or control groups. There were 
no differences between the MSA 3/ NBM and control group at the highest dose, nor were 
there any differences between groups at either the saline or the low scopolamine dose. 
Analysis of choice latencies (graph not shown) did not reveal a significant main 
effect, F(2,30)=1.86, p > 0.05. It did not reveal any injection condition by scopolamine 
dose interaction either, F(4,60)=1.09, p > 0.05. 
Overall, there were no significant differences between the 192-lgG saporin­
lesioned animals and the controls at either the saline or the low dose of scopolamine. The 
only parameter significantly affected at the high dose was the proactive errors. 
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DISCUSSION: 
The results of this study did not show any appreciable deficit of either recent or 
reference memory as measured by the RAM task following lesions of the basal forebrain 
using 192-lgG-saporin. The first experiment showed that the MSA 3/ NBM 2 group made 
significantly faster choices vvhen compared to the two other groups, but otherwise there 
were no differences between groups on any other measures. 
In the light of other studies using saporin, these results are neither surprising nor 
unexpected. Another study conducted in our lab at the same time as this one, in vvhich 
saporin from the same batch was used to lesion the MSA only, revealed that the saporin 
caused a marked depletion of AChE levels in the hippocampus, showing the saporin was 
working. We are thus reasonably certain that there was a marked cholinergic depletion 
in our animals, although we have not yet confirmed this with either neurochemical or 
histological analyses. 
There are a number of factors that may explain our not seeing an impairment. A 
study by Waite et al 42 concluded that at least a 85-95% depletion of ChAT was necessary 
before a behavioral impairment would be seen. They compared it to the >90% loss of 
dopaminergic neurons needed before the behavioral symptoms of contralateral turning 
become apparent (in the rat model of Parkinson's Disease). They suggest that perhaps 
this is the reason that the quisqualic and AMPA lesions of the NBM also did not produce 
a behavioral deficit, since they only depleted ChAT by 70-80%. It is possible that, even 
in our animals with five lesions, we did not induce a large enough depletion of ACh to see 
a deficit and that the brain was able to compensate for the loss. 
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If this was the case, however, we expected that we would see an impairment 
following injections of a subthreshold dose of scopolamine, just as Steckler et al had 
expected 20.. We believed that scopolamine would cause a greater deficit on the RAM in 
the 192-lgG saporin lesioned animals than in controls. In our other study, rats with MSA 
lesions only did show greater memory deficits when given subthreshold doses of 
scopolamine. Since the subthreshold dose had no measurable effects on our rats, we 
cannot conclude anything from that experiment. 
However, the "compensation" explanation does not explain why such profound 
deficits are seen with general antagonists like scopolamine or other excitotoxins such as 
ibotenic acid, which produce the same amount of cell loss and cholinergic depletion as 
quisqualic acid and AMPA. One plausible explanation is that scopolamine affects 
peripheral ACh receptors as 'Nell. These include cholinergic systems controlling salivation, 
heart rate, gastrointestinal motility, temperature, blood pressure, and efficient functioning 
of the lungs and bronchial tract 1. Animals on high doses of scopolamine not only exhibit 
motor and breathing problems, but their dry mouths prevent them from eating the 
reinforcers. In this study, only 50% of the rats on the high dose of scopolamine were able 
to complete the task. Thus, the observed deficits may be less attributable to memory 
deficits, and more due to the side effects. 
Another explanation is that excitotoxic damage is nonspecific. In fact, nearly every 
study using saporin that has found behavioral deficits has used either intraventricular 
injections (known to affect cerebellar PUrkinje cells) or has been at a high enough dose to 
affect other neurotransmitters as well 43. These results, along with numerous studies 
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involving manipulations of other transmitters in combination with acetylcholine, clearly 
show the involvement of other neurotransmitter systems in learning and memory. There 
is evidence for interactions between the cholinergic system and other systems such as 
serotonergic, GABAergic, and noradrenergic systems 6,17,28,36. Numerous studies have 
also shown that lesions to the NBM produce deficits on attentional tasks, leading Wellman 
et al 44 to conclude that the deficits induced by NBM lesions may be mediated by attention 
and motivation. 
Given the evidence against the exclusive role of ACh in learning and memory, it 
is somewhat surprising that most of the therapeutic drugs currently being tested for AD are 
specific to acetylcholine. In fact, drugs such as tacrine (Cognex), physostigmine, 
velmacrine, and others are currently being used to treat patients with the disease 21. 
These drugs work by increasing the amount of acetylcholine available in the affected 
areas of the brain, and they are meeting with limited success. Part of the reason for the 
failure of these drugs is that their mode of action is presynaptic. As AChE inhibitors, they 
prevent the breakdown of ACh and allow more of it to remain in the cleft. Unfortunately, 
in Alzheimer's Disease, the presynaptic fibers are degenerating. Thus there is less ACh 
present to begin with. AChE inhibitors may be useful in early stages of the disease, but 
for later stages there is not enough ACh for them to act on. 
One final possibility for our not finding behavioral deficits was that we may not have 
been using the right tests. As mentioned earlier, most of the saporin studies tested 
acquisition. We decided to test retention, our rationale being that any deficits we found 
would be due to the lesion, not due to a slower-learning group. By pretraining the rats, 
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we may have made the task too familiar. If the MSA and NBM are involved in acquisition 
and consolidation of events, then we of course would not have seen deficits. The second 
experiment was designed to control for that effect by introducing a new trial-specific 
element by interrupting the task and forcing the rats to remember where they had been 
before on that day. It may be that five minutes was not a long enough delay for effects to 
be seen. 
In conclusion, further studies on the interaction of neurotransmitter systems and 
the cholinergic system are warranted. While selective depletion of acetylcholine by 
saporin is not in itself a good model for AD, it will be incredibly useful in conjunction with 
toxins specific to other systems for determining these possible interactions. We plan to 
study the GABA system next, by giving these animals a GABA enhancing drug and testing 
them on the water maze. 
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FIGURE LEGENDS: 
Figure 1: 
A: Effects of combined immunolesions using 192-lgG Saporin on mean number of 
reference memory errors (entries into unbaited arms) during a standard partially-baited 
RAM task by male rats. 
B. Effects of combined immunolesions using 192-lgG saporin on mean number of recent 
memory errors (reentries into arms) during a standard partially-baited RAM task by male 
rats. Mean number of recent memory errors (reentries into arms). C. Effects of combined 
immunolesions using 192-lgG Saporin on the average latency per choice (total trial latency 
divided by number of choices) during a standard partially-baited RAM task by male rats. 
Each rat received one trial per day for sixteen days. Vertical lines represent standard 
errors. Groups are as follows: MSA 1/ NBM 2, n=12; MSA 3/ NBM 2, n=12; Controls, 
n=10. (*) indicates significantly different from the MSA 3/ NBM 192-lgG saporin lesioned 
group. (-) indicates significantly different from both other groups. (-) indicates 
significantly different from the MSA 1/ NBM 192-lgG saporin lesioned group. 
Figure 2 
A: Effects of combined immunolesions of the MSA and NBM on the mean number of 
reference memory errors (entries into arms that were never baited) during performance of 
a standard RAM task with a five-minute delay between the third and forth choices. B: 
Effects of combined immunolesions of the MSA and NBM on the mean number of 
retroactive memory errors (entries into unbaited arms that were baited and visited during 
--
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the pre-delay session of the trial) during performance of a standard RAM task with a five­
minute delay bet\Yeen the third and forth choices. C: Effects of combined immunolesions 
of the MSA and NBM on the mean number of proactive errors (reentries into any arm 
during the post delay session) during performance of a standard RAM task with a five­
minute delay bet\Yeen the third and forth choices. Vertical lines represent standard errors. 
Groups are as follows: MSA 1/ NBM 2, n=12; MSA 3/ NBM 2, n=11; Controls, n=10. 
Figure 3: 
A: Effects of two doses of scopolamine on the mean number of reference memory errors 
(entries into arms that were never baited) during performance of a standard RAM task with 
a five minute delay by rats with combined immunolesions of the MSA and NBM. B: Effects 
of two doses of scopolamine on the mean number of retroactive memory errors (entries 
into unbaited arms that were baited and visited during the pre-delay session of the'trial) 
during performance of a standard RAM task with a five minute delay by rats with combined 
immunolesions of the MSA and NBM. C: Effects of two doses of scopolamine on the 
mean number of proactive errors (reentries into any arm during the post delay session) 
during performance of a standard RAM task with a five minute delay by rats with combined 
immunolesions of the MSA and NBM. Each rat received one tr'ial per day for nine days. 
Vertical lines represent standard errors. Groups are as follows: MSA 1/ NBM 2, n=12; 
MSA 3/ NBM 2, n=11; Controls, n=10. (*) indicates that this group was significantly 
different from both of the other two groups. 
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